You knew something like this would happen.
Pfizer was supposed to complete a study on the occurrence of subclinical myocarditis, or heart inflammation, after receipt of its COVID-19 vaccine. The completion date was listed by the FDA in 2021 as June 20, 2022. Pfizer was also supposed to submit the results of the study to the FDA by the end of 2022 as part of a list of requirements the FDA imposed as a condition of approving Pfizer’s jab.
But after the deadline passed, the FDA quietly changed the date.
Under a list of postmarketing requirements for the Pfizer-BioNTech vaccine, the FDA now says the same study has an “original projected completion date” of June 30, 2023.
The current status of the study is listed as “pending.”
The FDA and Pfizer did not respond to requests for comment....
What 'comment' could they make? "Yah, FDA is covering our butt"? Or this: "FDA makes whatever rules we damn well want to make. Sit down and STFU!!"
At least those are honest.
and the hits keep comingReplyDelete
14 million views on Twitter: Most views in Veritas History
WAR ROOM: Steven Bannon & James O'Keefe Discuss Viral #DirectedEvolution Investigation
and right on schedule, Voxday Piles on.....
Hope this picks up steam.....They need to lose way moreReplyDelete
Pfizer Suffers Largest Monthly Loss Of Value Since 2009
Podcast Lindsey Jones: Pfizer Fraud Exposed by WhistleblowerReplyDelete
Lawsuit Aims To Overturn Pfizer’s Limited Liability, Opening Floor For American Citizens To Seek Justice
Texas Lindsey twitter feed: